Founded by former SpaceX engineers, Synthego is a leading provider of genome engineering solutions. The company's flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research. Synthego's vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist. Headquartered in Silicon Valley, California, Synthego customers include leading institutions in over 30 countries around the world and 9 of the top 10 global biology universities.
The Minerva Project
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Synthego or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
EQUITYZEN and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.